Nephrotoxic and cytoproliferative effects of streptozotocin.Report of a patient with multiple hormone-secreting islet cell carcinoma
- 1 October 1976
- Vol. 38 (4), 1550-1555
- https://doi.org/10.1002/1097-0142(197610)38:4<1550::aid-cncr2820380417>3.0.co;2-t
Abstract
The nephrotoxic and cytoproliferative side effects observed in a patient with Streptozotocin-treated, multiple hormone-secreting, pancreatic islet cell carcinoma are described. Streptozotocin induced prolonged partial remission of the patient's multiendocrine syndrome but resulted in progressive azotemia, which was controlled by temporary hemodialysis. A renal biopsy, the first to be reported in detail in such a condition, demonstrated a tubulo-interstitial nephritis and a glomerular alteration consisting of cellular nodules. At autopsy there were numerous bilateral renal cortical spindle cell “tumors” and cellular aggregates in glomeruli. These findings suggest that the tumorigenic effects of Streptozotocin demonstrated in animals may also occur in man.This publication has 30 references indexed in Scilit:
- Simultaneous ectopic production of parathyroid hormone and calcitoninMetabolism, 1976
- Streptozotocin Diabetes CORRELATION WITH EXTENT OF DEPRESSION OF PANCREATIC ISLET NICOTINAMIDE ADENINE DINUCLEOTIDEJCI Insight, 1974
- Streptozotocin Treatment of Metastatic Carcinoid TumorsSouthern Medical Journal, 1972
- Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinomaGut, 1971
- Notes on streptozotocin in metastatic insulinomaJournal of Surgical Oncology, 1971
- Streptozotocin treatment of malignant islet cell tumour.BMJ, 1970
- TREATMENT OF INSULINOMA WITH STREPTOZOTOCINThe Lancet, 1969
- TREATMENT OF MULTIPLE-HORMONE-PRODUCING MALIGNANT ISLET-CELL TUMOUR WITH STREPTOZOTOCINThe Lancet, 1968
- Structure of streptozotocinJournal of the American Chemical Society, 1967
- Induction of Renal Tumour by Streptozotocin in RatsNature, 1967